Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice the first side effects of Wegovy within a few hours to two days of their initial injection, though the timing varies. Nausea is the most commonly reported early symptom and tends to peak in the first 24–48 hours after each new dose or dose increase. These reactions are a predictable part of how semaglutide works, not a sign that something has gone wrong. Wegovy is a prescription-only medicine; a clinical assessment with a prescriber is required before starting, and that conversation is the right place to talk through what to expect.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer: often the same day. Semaglutide slows the rate at which food leaves your stomach and acts on appetite centres in the brain, and both effects can produce noticeable sensations fairly quickly. If you're wondering how long after taking Wegovy nausea tends to start, it commonly begins within a few hours of the first injection. Loose stools, burping or a feeling of fullness after very small amounts of food may follow in the first 48 hours.
That said, some people feel almost nothing after the initial 2.5 mg dose. The starter dose is deliberately low — its purpose is to let your system adapt gradually rather than produce immediate therapeutic weight loss. Because it's gentle on the stomach, the first few weeks can pass with only mild, fleeting symptoms for certain patients. If you're in that group, side effects may become more noticeable when the dose steps up. The full Wegovy side effects profile covers the whole titration journey in more detail.
The NHS medicines information for semaglutide notes that the most common side effects are gastrointestinal and that they tend to be most pronounced early in treatment or after a dose change, which aligns with what patients typically report in practice. You can read the NHS's own summary at nhs.uk/medicines/semaglutide.
Each time your prescriber increases the dose (from 0.5 mg to 1 mg, from 1 mg to 1.7 mg, and so on) your body is, in effect, meeting a stronger version of the medicine for the first time. The same mild adjustment process that happened on the first injection tends to repeat, sometimes with slightly more intensity as the dose climbs.
This pattern catches people off guard. It's completely understandable to feel reassured that things have settled, then frustrated when symptoms reappear after a step-up. For anyone trying to plan ahead, our page on how long after taking Wegovy you can expect to feel side effects explains the typical timeline in detail. Practical things that genuinely help (eating smaller portions, avoiding rich or fatty foods on injection day, keeping hydrated) are worth trying if nausea is disrupting your routine. Our guide to managing Wegovy nausea has specific, practical suggestions.
If side effects at a particular dose feel genuinely unmanageable, that's a conversation for your prescriber rather than something to push through alone. Slowing the titration pace is a recognised clinical option.
Beyond the GI cluster, a small number of people report mood changes emerging over weeks to months of treatment rather than immediately. Wegovy's effect on brain signalling is still being researched, and if you notice shifts in low mood or unusual thoughts, raising this with your prescriber early is the right move. Our page on Wegovy and mood changes covers what's currently known.
Hair thinning is another symptom that occasionally appears later (typically several months into treatment) and is usually linked to rapid weight loss rather than semaglutide directly. It tends to resolve, but again, your prescriber is the person to involve if it concerns you.
A fuller picture of the side-effects landscape, including less common reactions, is on our overview of Wegovy side effects. The Wegovy SmPC on the eMC also lists the complete frequency data from clinical trials if you want the technical detail.
This is where sitting tight is the wrong call. Most nausea and loose stools can be managed at home, but certain symptoms need a clinician the same day.
Severe abdominal pain that radiates to your back, especially with vomiting, may point to pancreatitis, a known, infrequent but serious side effect. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as a risk with GLP-1 medicines, including semaglutide, and advising patients to seek urgent help for that symptom pattern. Don't try to manage it with antacids and wait.
Other situations that need prompt assessment: signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, rapid heartbeat), persistent vomiting that stops you keeping fluids down for more than a day, or any symptoms of gallbladder problems such as pain in the upper right abdomen. If you're uncertain, call 111 or contact your prescriber directly.
Any suspected side effect from Wegovy can also be reported via the MHRA Yellow Card scheme, patients can report directly, and it genuinely contributes to ongoing medicine safety monitoring.
If you're considering Wegovy and want to understand exactly what to watch for, our prescribers discuss side-effect timing and management as part of every consultation. You can check your eligibility and start a free consultation with no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.